Population Health Weekly

Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode! For thirty years, Juan wrote the standards. In his final year, he tried to make his agency faster. The hardware arrived. The backlog cleared. Reviews that took months took days. Then the Phase IV data came in — and the drugs worked. The wards were still full. This is the story of a regulator wh...

Got something to say to this podcast? Send a voicemail, and you might hear yourself on the next episode! I thought the hardest part was over. Then the real work began. This is a first-hand account of a large Phase 3 global randomized clinical trial — the stage where a drug proves itself in thousands of patients, or disappears. From a site with no trained staff, one refrigerator on the fourth floor...

A lamb has bolted the barn door. The bacteria told her machines can now do what animals have done for a century. So she will not bleed. Six sheep wait outside. Two guinea pigs watch from the corner — they have seen it all before. What follows is a rare dialogue between species: an old ram, a young striker, and a flock asking whether biopharma still needs them as technology reshapes the pipeline, d...

A Himalayan lion watches a road cut through a valley he has known since cubhood. A biochemist climbs to meet him. Between them sits a question that decides which diseases get studied — and which are left behind. Every medicine begins with a target. A lock in the body — an enzyme, a receptor, a gene. The key must fit. But the lock must be chosen first. And choosing is excluding. Of every ninety mol...

Coming up throughout October 2026

Four floors. One building. At the top, an office that is always empty. Polished wood. Fresh flowers. A coffee cup, still warm, left mid-sip. This is where the series ends. Not with a verdict — with a choice. We trace leadership risk from mid-century travel accidents to today's cognitive overload and moral injury. We name what almost no one names: not what leaders face, but how fast they face it. T...

The elevator opens on the third floor. No biometric queues. No charging stations. Just carpet that absorbs footsteps and doors that stay closed. This is where managers translate—between the noise below and the silence above. On a mantelpiece sit two relics: a rotary handset and a BlackBerry. They have not rung in years. They have not been needed. But they remember. This episode is unlike any other...

He takes the stairs. At sixty-four, Bala supervises the night shift on the first floor—the invisible cadre that keeps the global economy breathing. Banking analysts. Hospital coders. Hospitality managers. Delivery dispatchers. In this episode, we trace the history of occupational disease across five decades—from silicosis to algorithmic fatigue—and expose a quiet crisis: injury reporting has decli...

The elevator never stops ringing. The ground floor never empties. And Meera—receptionist, observer, witness—is learning that the cost of seeing is now hers to bear. In this episode, we walk into the world of biometric queues, charging wars, and the silent erosion of sight and sleep. We trace the history of occupational health— from the Factory Acts of 19th-century Britain to Soviet health screenin...

You have heard the talk. AI. Automation. The future of work. But we are not talking about the future. We are talking about right now. The warehouse picker, hounded by an algorithm counting every second. The gig driver, hunted by schedules that never stop. The remote coder, glued to screens long after sunset. The CEO, pacing before a shareholder meeting, running on caffeine and cortisol. Different...

In this concluding episode of The Digital Scar, we move from diagnosis to action. Drawing on the public health lessons of motorization—where research transformed a deadly sport into a safer one—we outline a blueprint for addressing the health impacts of digital exposure. Key actors must work together: Epidemiologists to lead the evidence Manufacturers to design with health in mind Regulators to se...

We measure screen time with precision, but we don't measure its health impact. Road deaths, hearing loss, myopia—statistics exist, but attribution to digital devices is missing. ICD-10 has a code for digital distraction, yet it's almost never used. Meanwhile, research on mobile health is dwarfed by other fields. The data exists. The will doesn't. And Erin Rodgers shines The Spotlight on something...

A brilliant pathologist sees cellular damage in younger bodies—damage once reserved for textbooks. The evidence for hearing loss from earbuds seems convincing. The evidence for eye changes is growing. But for the brain? Still unclear. For posture-related injuries? Unproven. The picture is fragmented, the gaps wide. Ana knows she cannot solve this alone. A former colleague— an epidemiologist who se...

Alex and Jordan—born in South Africa. One stayed. One moved to Brazil. Both countries now lead the world in screen time—over 9 hours daily. Different paths, same exposure. A 25-year experiment with no control group. Will we act before it costs another generation? And Dr Bilal Zafar summarizes how digital or eHealth has transformed the care of diabetes in The Dispatch. Also includes moments of Erin...

How do we measure progress when the devices that keep us working and socializing around the clock may be quietly reshaping our biology? This series continues our exploration of the changing global health landscape—following our examination of elderly care in the aftermath of the industrial age and digitalization's impact on healthcare itself. Understanding digitalization's full health impact is no...

Britain's aviation collapse was a failure of governance and integration. Digital health faces the same risk—but the Al‑Rashids show adaptation is possible. Rising energy demand is spurring renewable energy investment, yet e‑waste and manufacturing culture lag. D emand for equitable self‑care devices remains unmet. The transformation has begun. Will it serve everyone? Also includes listener feedbac...

Rwanda's drones deliver blood in minutes. India's telemedicine platform connects millions. Andalucía's integrated network keeps chronic patients at home. Each succeeds—each has trade‑offs. Who still gets left behind? Evidence from the field. Listen, apply, and adapt. Also includes Erin Rodgers' verdict on the observer who went across continents evaluating the three health projects. And then she sh...

A healthcare data breach exposed 190 million records. Why? Infrastructure is not just servers—it's data centres, networks, and people. But data centres consume resources, generate e‑waste, and outpace retraining. The governance gap that enables breaches now fuels toxic waste and worker neglect. Build equitable infrastructure—or digital health fails. And Erin Rodgers brings back The Triad, the coll...

Seatbelts proved fitting technology isn't enough. We dissect digital health's regulatory race: privacy, AI bias, liability, insurer exclusion, and fragmented records. Can we mandate safety for the Global South before errors or cyberattacks force our hand? And as always, Erin Rodgers shines the Spotlight on the dark epidemic of sleeplessness and the enormous costs we're all paying for it. Content c...

We accompany a semiurban family as they face various aspects of healthcare being digitalized rapidly. This is an unprecedented and little-documented shift happening while health disparities and disproportionate disease burdens were already at all time high. The change is irreversible as new medical vocabulary and commercial realities have emerged. AI diagnostics, wearables, electronic health recor...

This month, going many steps further than merely seeing something huge happening before all of our eyes.

This finale confronts the high‑stakes dilemma: human control vs autonomous algorithms in elderly care. In low‑income regions with weak oversight, AI without empathy threatens to isolate, not rescue. Content creator declares no prejudice against an individual, a group, or any entity.

The third episode of our ongoing series is all about courage and conscientiousness that solves global health problems in a timely manner. Back in 2001, Jamie Love from USA ended up in India with Dr Yusuf Khwaja Hamied, Head of Cipla, a leading Indian generic drug manufacturer. As they say, the rest is history. This is a tale worth telling as we analyze the access to affordable drugs in this episod...

We explore the cascading impacts of ageing both within and outside the human body, connecting personal struggles to national policy battles. It expands on the opening episode of June 5 2026, while presenting this month's series: The Rise and Rise of the Elderly. And co-host Erin Rodgers shines her Spotlight for the very first time in the show. The content creator declares no prejudice against any...

This is the first episode of this month's series The Rise and Rise of the Elderly: Living with the Unintended Consequences of Public Health in the Industrial Age. It discusses the lessons in the aftermath of famous wins by a legendary football club and healthcare. The upload also includes The Triad, a unique collection of three professional updates from the biomedical world. You can post your thou...